Mary Kay Fenton, EVP and CFO at ACHILLION PHARMACEUTICALS INC (ACHN), sold 13,125 shares at $16.00 ($210K) on 2015-01-23, disclosed to the SEC on 2015-01-23.
Scheduled sale ($210k) by EVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACHN | SELL | 2015-12-30 | $438K | — | Filing → |
| ACHN | SELL | 2012-01-11 | $168K | — | Filing → |
| ACHN | SELL | 2011-04-06 | $32K | — | Filing → |